Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation
November 10th, 2017
8K views
This protocol describes the use of centrifugal elutriation to separate primary acute lymphoblastic leukemia cells into different cell cycle phases.
Overview
This protocol describes the use of centrifugal elutriation to separate primary acute lymphoblastic leukemia cells into different cell cycle phases. This method enables the investigation of phase-dependent effects of anti-cancer compounds.
Key Study Components
Area of Science
- Cell biology
- Cancer therapeutics
- Cell cycle analysis
Background
- Centrifugal elutriation is a technique used to isolate cells based on their physical properties.
- Understanding cell cycle phases is crucial for cancer research.
- Isolation of cells allows for targeted studies on the effects of treatments.
- This method avoids chemical perturbations, providing a purer analysis of cell behavior.
Purpose of Study
- To isolate acute lymphoblastic leukemia cells into distinct cell cycle phases.
- To facilitate research on the effects of anti-cancer compounds.
- To improve understanding of cancer cell dynamics.
Methods Used
- Installation of strobe assembly in the centrifuge.
- Adjustment of strobe flash lamp for optimal viewing.
- Utilization of centrifugal elutriation for cell separation.
- Observation of cells during the separation process.
Main Results
- Successful separation of leukemia cells into different phases.
- Ability to study phase-dependent responses to anti-cancer treatments.
- Demonstration of the effectiveness of centrifugal elutriation.
- Insights gained into the dynamics of cancer cell cycles.
Conclusions
- Centrifugal elutriation is a valuable tool for cancer research.
- Isolation of cells into specific phases enhances therapeutic studies.
- This method can lead to improved cancer treatment strategies.
Frequently Asked Questions
What is centrifugal elutriation?
Centrifugal elutriation is a technique used to separate cells based on their size and density.
Why is cell cycle phase separation important?
It allows researchers to study how different phases respond to treatments, which is crucial for developing effective cancer therapies.
What types of cells can be separated using this method?
This method can be used to separate various types of cells, including cancer cells like acute lymphoblastic leukemia.
Are there any chemical perturbations involved in this method?
No, centrifugal elutriation relies on physical properties for separation, avoiding chemical influences.
How does this method improve cancer research?
By allowing for precise isolation of cell phases, it enhances the understanding of cancer cell behavior and treatment responses.
Executive Industry Relevance
Isolating primary acute lymphoblastic leukemia cells into defined cell cycle phases enables mechanistic interrogation of anticancer compound activity, supporting target validation and lead identification in oncology drug discovery. This approach reduces biological noise from asynchronous populations, improving predictive confidence in preclinical efficacy assessments. By avoiding chemical synchronization artifacts, the method provides a disease-relevant system for de-risking cell cycle-dependent mechanisms of action.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of phase-specific drug effects to clarify therapeutic hypotheses and pathway dependencies.
- Operational Value: Provides enriched G1 and G2/M populations without chemical perturbations, reducing confounding variables in target validation assays.
Screening & Assay Development
- Scientific Value: Generates quantitative cell cycle phase distributions via flow cytometry, supporting assay standardization for compound screening.
- Operational Value: Produces highly enriched fractions in excellent yield, enabling reproducible preparation of disease-relevant cellular systems for downstream applications.
Translational & Preclinical Research
- Scientific Value: Supports mechanistic de-risking by linking cell cycle phase to protein biomarkers such as phospho-Rb and Cyclin B1.
- Operational Value: Facilitates continuity from discovery through preclinical validation using immunoblot-compatible, phase-pure lysates.
Pipeline & Workflow Integration
The method integrates into early discovery workflows by enabling hypothesis-driven testing of cell cycle-dependent drug responses prior to lead optimization.
- Discovery Biology: Supports pathway clarification and biological de-risking through phase-resolved analysis of anticancer compound activity.
- Screening: Enables assay readiness via standardized, reproducible isolation of leukemia cells into G1 and G2/M phases.
- Analytics: Delivers quantitative DNA content and protein expression readouts that allow comparison of compound effects across cell cycle phases.
- Translational Research: Connects to preclinical continuity through biomarker-aligned fractions suitable for immunoblot and functional assays.
- Enterprise Reuse: Establishes a reusable capability for generating phase-specific primary leukemia cells across multiple projects.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation through reduction of mechanistic ambiguity in cell cycle phase-specific responses.
- Operational Value: Standardization and reproducibility via physical separation based on size and density, avoiding chemical synchronization artifacts.
- Strategic Value: Better go/no-go decisions by enabling phase-specific efficacy profiling, reducing late-stage biological risk in oncology pipelines.
- Portfolio Impact: Risk-adjusted prioritization of compounds based on cell cycle-dependent activity profiles.
Implementation Considerations
- Requires expertise in centrifugal elutriation setup, including rotor balancing, tubing connections, and flow rate optimization.
- Dependent on access to a compatible centrifuge with variable speed control and strobe synchronization capability.
- Necessitates standardized elutriation buffer and sterile, pyrogen-free fluid handling to maintain cell viability and fraction purity.
- Adaptation to other primary tumor cells may require optimization of flow rates and centrifugation speeds based on cell size and density.
- Practical limitations include lower throughput compared to chemical synchronization and the need for specialized equipment not universally available in all discovery labs.
Biopharma FAQs
Why does isolating cells into G1 and G2/M phases matter for target validation?
Isolating cells into distinct cell cycle phases allows researchers to interrogate phase-dependent effects of anticancer compounds, which is critical for validating targets that function specifically in certain phases. This approach reduces noise from asynchronous populations and improves the precision of mechanism-of-action studies in primary leukemia cells.
How does centrifugal elutriation enable independent variable isolation in the discovery pipeline?
The technique separates cells based on physical properties like size and density, allowing cell cycle phase to be isolated as an independent variable without chemical perturbations. This enables clean interrogation of how therapeutic compounds affect cells in specific phases, supporting hypothesis testing in early discovery.
What quantitative dependent variable measurements does this method enable for drug response analysis?
The method enables quantitative measurements such as DNA content via flow cytometry and protein expression levels via western blotting, which serve as dependent variables to assess drug effects. These readouts allow comparison of compound activity across G1, S, and G2/M phases in primary leukemia cells.
Why are replication requirements important for cross-functional collaboration in elutriation-based studies?
Replication ensures that phase separation results are consistent across runs, which is essential for generating reliable data that can be shared between discovery biology, assay development, and preclinical teams. Consistent yields of G1 and G2/M fractions support standardized assay handoffs and comparative analysis.
What statistical analysis capabilities are required before implementing centrifugal elutriation in a discovery workflow?
Teams must be able to analyze flow cytometry data to quantify phase distribution and apply statistical tests to compare enrichment levels across fractions. This capability is necessary to validate separation purity and assess the significance of phase-dependent drug responses in follow-up experiments.
Chapters in this video
0:05
Title
0:41
Assembling the Elutriation System
2:55
Priming the Elutriation System
4:56
Introduction of Cell Sample into the Elutriation System and Collection of Fractions
6:56
Results: Evaluation of Centrifugal Elutriation-based Sorting of Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases
8:21
Conclusion
